2019 Transparency Market Research, All Rights Reserved

Transcription

1 Antiviral Drugs Market Segmentation by Disease Indication - Hepatitis Virus Infection, HIV Infection, and Respiratory Virus Infection; Product Type - Branded Drugs and Generic Drugs; Distribution Channels - Hospital Pharmacy Store, Retail Pharmacy Store, and Online Pharmacy, and Forecast,

2 Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Content Preface Assumptions and Research Methodology Market Overview Market Dynamics Global Antiviral Drugs Market Analysis and Forecasts, By Software Type Global Antiviral Drugs Market Analysis, by Modality Global Antiviral Drugs Market Analysis, by Application Global Antiviral Drugs Market Analysis, by End-user Global Antiviral Drugs Market Analysis and Forecast by Region Europe Antiviral Drugs Market Analysis and Forecast Asia Pacific Antiviral Drugs Market Analysis and Forecast Latin America Antiviral Drugs Market Analysis and Forecast Middle East & Africa Antiviral Drugs Market Analysis and Forecast Competition Landscape

3 Antiviral drugs refer to those prescription medicines that are capable of fighting against flu viruses in one s body. Antiviral drugs could include intravenous solutions, an inhaled powder, liquid, or pills. The global antiviral drugs market is likely to observe considerable growth due to the rising incidences of viral infections. As coronavirus spreads at an exponential rate and the number of deaths crosses 74,000 worldwide, efforts are being made to lessen transmission through standard public health interventions. These interventions are based on tracing of contacts and isolation of cases. So far, there is no drug or vaccine to contain the spread of the pandemic worldwide.

4

5 The global antiviral drugs market will exhibit a healthy CAGR of 6.40% during the forecast period of 2016to The global antiviral drugs market is projected to rise at a significant pace in the coming few years. Availability of strong product pipeline is another factor expected to propel the growth of the global antiviral drugs market in the coming years. As per a study, over 36 million people around the globe are suffering from HIV infection in Further, the population in the region touched 2.0 million new cases of HIV.

6 Researchers and doctors have observed that antiviral drugs administered shortly after the onset of symptoms can diminish the infectiousness to others through diminished viral shredding in the patient s respiratory secretions. Growing prevalence of viral diseases such as malaria, dengue, chikungunya, and other deadly viral diseases is prompting an ever increasing demand for these antiviral drugs from these regions. Some of the key players in the global antiviral drugs market include names such as Merck & Co. Inc., Johnson and Johnson, Schering-Plough Corporation, AbbVie Inc., and AstraZeneca Plc. among others.

7 To know more about us, please visit our website For sales queries or new topics us on: Thank You